Search results for "Guideline"

showing 10 items of 800 documents

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a pa…

2020

Summary The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be general…

Adultmedicine.medical_specialtyMyeloidCoronavirus disease 2019 (COVID-19)Pneumonia ViralPopulationCovid 19 hematological neoplasia managementMEDLINEArticleResource AllocationBetacoronavirus03 medical and health sciences0302 clinical medicinePandemicHumansMedicineDisease management (health)Intensive care medicineeducationExpert TestimonyPandemicsInfection Controleducation.field_of_studyLeukemiaMyeloproliferative DisordersSARS-CoV-2business.industryPublic healthCOVID-19Disease ManagementHematology3. Good healthClinical trialmedicine.anatomical_structure030220 oncology & carcinogenesisPractice Guidelines as TopicCoronavirus Infectionsbusiness030215 immunology
researchProduct

Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithias…

2019

Bladder stones (BS) constitute 5% of urinary stones. Currently, there is no systematic review of their treatment.To assess the efficacy (primary outcome: stone-free rate [SFR]) and morbidity of BS treatments.This systematic review was conducted in accordance with the European Association of Urology Guidelines Office. Database searches (1970-2019) were screened, abstracted, and assessed for risk of bias for comparative randomised controlled trials (RCTs) and nonrandomised studies (NRSs) with ≥10 patients per group. Quality of evidence (QoE) was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool.A total of 2742 abstracts and 59 full-text article…

Adultmedicine.medical_specialtyPercutaneousUrologymedia_common.quotation_subject030232 urology & nephrologyUrologyContext (language use)law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawLithotripsyUreteroscopymedicineHumansChildSocieties Medicalmedia_commonUrinary Bladder Calculibusiness.industryConvalescenceGuidelinemedicine.diseaseEurope030220 oncology & carcinogenesisMeta-analysisRelative riskPractice Guidelines as TopicBladder stonesbusinessEuropean Urology
researchProduct

CT exposure in adult and paediatric patients: a review of the mechanisms of damage, relative dose and consequent possible risks.

2014

An increase has been observed not only in the absolute number of CT examinations but also in the length of coverage and number of scanning phases, with the result that exposure to ionising radiation from CT is becoming an increasingly serious problem. The extent of the problem is not entirely known and cannot be adequately addressed without proper knowledge of all the phases that leads to the effective dose calculation. In light of the growing awareness of the issue of ionising radiation dose and the possible risk for the individual and the population, there is a need for radiologists, medical physicists and radiographers to play an active role in dose management. In this review, the author…

Adultmedicine.medical_specialtyPopulationGuidelines as TopicRadiation DosageEffective dose (radiation)PediatricsRisk AssessmentCaliforniaRadiation ProtectionRisk FactorsNeoplasmsRadiation Ionizingmedicinemedia_common.cataloged_instanceHumansRadiology Nuclear Medicine and imagingMedical physicsEuropean UnionEuropean unioneducationChildMathematical ComputingNeuroradiologymedia_commoneducation.field_of_studyEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryCT Radiation exposure DLP CTDI Radiation dose Absorbed doseInterventional radiologyGeneral MedicineEvidence-based medicineAbsorbed doseRadiologyRisk assessmentbusinessRadiologyTomography X-Ray ComputedLa Radiologia medica
researchProduct

Development and implementation of guidelines for the management of depression: a systematic review

2020

To evaluate the development and implementation of clinical practice guidelines for the management of depression globally.We conducted a systematic review of existing guidelines for the management of depression in adults with major depressive or bipolar disorder. For each identified guideline, we assessed compliance with measures of guideline development quality (such as transparency in guideline development processes and funding, multidisciplinary author group composition, systematic review of comparative efficacy research) and implementation (such as quality indicators). We compared guidelines from low- and middle-income countries with those from high-income countries.We identified 82 nati…

Adultmedicine.medical_specialtySystematic Reviewsmedia_common.quotation_subject030231 tropical medicine03 medical and health sciences0302 clinical medicineMultidisciplinary approachmedicineHumansGuideline developmentQuality (business)media_commonDepressive Disorder MajorDepressionbusiness.industryPublic Health Environmental and Occupational HealthEfficacy researchfeasibility studyGuidelineGuideline implementationFamily medicineTransparency (graphic)health impactbusinessguidelineManagement of depressionnervous system disorder
researchProduct

A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce

2021

Background: Although well described in adults, there are scarce and heterogeneous data on the diagnosis and management of chronic urticaria (CU) in children (0-18 years) throughout Europe. Our aim was to explore country differences and identify the extent to which the EAACI/GA²LEN/EDF/WAO guideline recommendations for paediatric urticaria are implemented. Methods: The EAACI Taskforce for paediatric CU disseminated an online clinical survey among EAACI paediatric section members. Members were asked to answer 35 multiple choice questions on current practices in their respective centres. Results: The survey was sent to 2,773 physicians of whom 358 (13.8%) responded, mainly paediatric allergist…

Adultmedicine.medical_specialtyUrticariaImmunologyDermatologyOmalizumabOmalizumaburticaria diagnosischronic urticariaSecond lineSurveys and QuestionnairesHumansImmunology and AllergyMedicineChronic UrticariaChildChronic urticariachildurticaria treatmentbusiness.industryTask forceGuidelineThird lineFamily medicineChronic DiseasePediatrics Perinatology and Child HealthHistamine H1 AntagonistsomalizumabAllergistsApproaches of managementbusinessmedicine.drug
researchProduct

Political issues in internal medicine in Europe. A position paper

2004

Abstract What will be the future of internal medicine in Europe? Because of rapidly growing concerns regarding the position of internal medicine in many European countries, the European Federation of Internal Medicine (EFIM) has established a working group to analyze the situation. Being well aware of the variation in working practices in the different countries, the members of the group used an “all-European” approach to answer the following questions: • Are there problems for internal medicine? If so, what are these problems and why? • Why do the health care systems in the European countries need internal medicine? • Why do patients need internal medicine? • What needs to be done? Interna…

Adultmedicine.medical_specialtyhealth care facilities manpower and servicesmedia_common.quotation_subjecteducationPoliticsInternal medicineHealth careInternal MedicineHumansMedicineGuidelines and standardsSocieties Medicalhealth care economics and organizationsmedia_commonAdult patientsDelivery of Health Care Integratedbusiness.industryHealth care deliveryPoliticsCornerstoneHealth care deliveryEuropeService (economics)MedicinePosition (finance)Position paperFamily PracticebusinessDelivery of Health CareForecastingSpecializationEuropean Journal of Internal Medicine
researchProduct

Electrocardiography plus limited echocardiography in young, newly identified, hypertensives: some considerations.

2010

Adultmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCost-Benefit AnalysisAge FactorsElectrocardiography echocardiography left ventricular hypertrophy hypertensionGuidelines as TopicMiddle AgedElectrocardiographyEchocardiographyInternal medicineHypertensionInsurance Health ReimbursementInternal MedicineCardiologymedicineHumansHypertrophy Left VentricularbusinessElectrocardiographyAmerican journal of hypertension
researchProduct

Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patient…

2016

In the treatment of breast cancer, decisions on adjuvant treatment reflect individual patient characteristics like age and comorbidity. This study assessed the association between adherence to guidelines for adjuvant treatment and survival while taking into account age at diagnosis and comorbidities. We collected the Charlson comorbidity index at baseline for 2179 women treated for primary breast cancer from 1992 to 2008 who participated in a German retrospective multicenter cohort study. We assessed subsequent adjuvant therapy guideline adherence and survival in relation to baseline comorbidities. Guidelines for adjuvant chemotherapy and radiotherapy were more often violated in patients wi…

Adultmedicine.medical_specialtymedicine.medical_treatmentBreast NeoplasmsComorbidityKaplan-Meier EstimateDisease-Free Survival03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineOutcome Assessment Health CareInternal MedicinemedicineAdjuvant therapyHumans030212 general & internal medicineAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overbusiness.industryHazard ratioAge FactorsRetrospective cohort studyGuidelineMiddle Agedmedicine.diseaseComorbiditySurgerySurvival RateOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisSurgeryFemaleGuideline AdherencebusinessMastectomyCohort studyFollow-Up StudiesThe breast journal
researchProduct

Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus

2014

Aged 80 and overmedicine.medical_specialtyPhysiologybusiness.industryDiabetes MellituBlood PressureMiddle Agedmedicine.diseaseBlood pressureInternal medicineDiabetes mellitusHypertensionPractice Guidelines as TopicDiabetes MellitusInternal MedicineHumansMedicineIn patientCardiology and Cardiovascular MedicinebusinessHumanAgedJournal of Hypertension
researchProduct

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

2020

Abstract Background In 2016, an expert working group was convened under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and formulated consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia. Aims The objective of the current paper is to provide a 2020 update of the previous recommendations in accordance with the evidence that has become available since our original recommendations. Methods This paper is based on literature reviews performed by members of the ESCEO working group and followed up with face to face meetings organized for the whole group to make amendments and discuss…

AgingSarcopeniaGeriatrics & GerontologyStandardizationDiseaseReviewRecommendationsFace-to-face0302 clinical medicineQUALITY-OF-LIFEGAIT SPEEDClinical trial; Drug registration; Guidelines; Recommendations; Sarcopenia; Treatment; Aged; Humans; Muscle Strength; Osteoarthritis; Osteoporosis; Pharmaceutical Preparations; Sarcopenia030212 general & internal medicineMUSCLE MASSDIETARY-PROTEINClinical trialPhysical limitationsPharmaceutical Preparations/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPatient-reported outcomeGRIP STRENGTHLife Sciences & Biomedicinemedicine.medical_specialtyNUTRITIONAL-STATUSBODY-COMPOSITION030209 endocrinology & metabolismGuidelines03 medical and health sciencesClinical trial · Sarcopenia · Guidelines · Recommendations · Drug registration · TreatmentSDG 3 - Good Health and Well-beingOsteoarthritismedicineHumansMuscle StrengthDrug registrationAgedScience & Technologybusiness.industryWORKING GROUPmedicine.diseaseComorbidityClinical trialTreatmentSarcopeniaPATIENT-REPORTED OUTCOMESPhysical therapyOsteoporosisGeriatrics and GerontologyPHYSICAL PERFORMANCEbusinessAging Clinical and Experimental Research
researchProduct